Sahajanand Medical Technologies logo

Sahajanand Medical Technologies IPO

GMP, Subscription, Price, Allotment, Listing Date & AI Prediction

Upcoming

Mainboard

PRICE BAND

Rs 327 - 344

LOT SIZE

43

Shares

MIN INVEST

Rs 14,792

CUT-OFF

Rs 344

per share

Open

15 Oct 2026

Last Day

19 Oct 2026

Allotment

21 Oct 2026

Expected Refund

22 Oct 2026

Listing

23 Oct 2026

GMP Today

5m ago

+11.6%

+Rs 40 premium

Refresh in --:--
GMP Graph

Est. Listing Price

GMP Based

Rs 384

Issue Price + GMP (Dynamic)

Est. Profit (1 Lot)

GMP Based

+Rs 1,720

+11.6% (43 shares)

Subscription

-

Not open

Sub. Page
IPOGyani AI Engine - Live Prediction
+7.6%

Range: +3.6% to +11.6%

Confidence: Moderate - 54%

Confidence Score - 54%

📈 GMP Trend⚓ Anchor Quality🧠 Sentiment 54/100📊 Sub 0x🏭 Medical Devices & MedTech
Next refresh: --:---Updated: --:-- IST-Model: IPOGyani v2.1

Live Subscription Tracker

Real-time subscription data

Subscription data will appear when IPO opens

Current IPO Status: upcoming

Summarize with AI

Get a quick Sahajanand Medical Technologies summary (150-200 words) from your favorite AI:

ChatGPTClaudeGemini

About Sahajanand Medical Technologies

Medical Devices & MedTech

The company operates three manufacturing facilities, two in India and one in Thailand, supported by two research and development centres in India and Thailand. As of June 30, 2026, it had 119 patents granted globally, 78 patent applications in the pipeline and five design registrations in India. Its products were marketed in 77 countries in Fiscal 2026. Its flagship brands include Supraflex Cruz, Cocoon and Hydra. The company serves domestic and international markets through direct, hybrid and distributor-led sales channels.

IPO_DETAILS_LONG: Sahajanand Medical Technologies IPO is a Mainboard book-built issue comprising an Offer for Sale of 1,38,22,116 equity shares with a face value of ₹1 each. The issue size is approximately ₹475.48 Cr at the stated upper price band of ₹344 per share. The price band is ₹327 to ₹344, and the lot size is 43 shares. The IPO opens on October 15, 2026 and closes on October 19, 2026. Allotment is scheduled for October 21, refund and demat credit for October 22, and listing on BSE and NSE for October 23, 2026. The offer is entirely an OFS, so the company will not receive proceeds from the issue. The selling shareholders will receive the sale proceeds.

Issue Details

Total Issue Size

Rs 475 Cr

Issue Size for Retail

Rs 166.42 Cr

Fresh Issue vs OFS

OFS
Rs 475.48 Cr (100%)

Reservation Quota

QIB

50%

Retail

35%

NII

15%

Lead Manager

Motilal Oswal Investment Advisors Ltd.; Avendus Capital Pvt. Ltd.; HSBC Securities & Capital Markets (India) Pvt. Ltd.; Nuvama Wealth Management Ltd.

Registrar

MUFG Intime India Pvt. Ltd.

Objects of the Issue (as per DRHP)

  • 1Offer for Sale by existing shareholders; proceeds go to the selling shareholders, not the company

Key Performance Indicator (KPI)

KPIJun 30, 2026Mar 31, 2026
ROE2.07%10.35%
ROCE3.16%11.57%
Debt/Equity0.330.27
RoNW2.31%10.60%
PAT Margin4.29%5.71%
EBITDA Margin13.81%14.10%
Price to Book Value5.48
Check IPO Peer Comparison here.
Pre IPOPost IPO
EPS (Rs)6.805.94
P/E (x)50.5957.91
Promoter Holding40.82%36.20%
Market CapRs 3496.65 Cr.

Bhargav Dhirajlal Kotadia; Dhirajlal Vallabhbhai Kotadia; Priyanka Dhirajlal Cohen; Shree Hari Trust

Sahajanand Medical Technologies Financials

Company financial data by reporting period. Amounts in Rs crore; ratios and percentages as labelled. A dash means not available, not zero.
MetricFY24FY25FY26
Total Income908.591,035.961,218.73
Net Profit (PAT)-7.3525.1569.08
EBITDA110.05128.02170.66
Borrowings175.27224.96269.53
ROENANA10.35%
ROCENANA11.57%
Debt/EquityNANA0.27
Assets970.581,094.91,276.43

Company Financials

Financial charts load as you reach this section.

MARKET SENTIMENT SCORE

0
50
100
54
Neutral

Based on expert reviews, GMP trends & market signals

Expert Reviews & Opinions

1
Positive
0
Neutral
0
Negative
MoneycontrolNewsPositive

By Sunil Shankar Matkar

Reports FY26 revenue growth of 18.1% to ₹1,210.5 Cr and profit growth of 174.65% to ₹69.1 Cr. The company sells medical devices across 65 countries, supporting its international growth profile. Investors should assess valuation, product-market concentration and the final IPO terms.

11 Oct 2026View Source

Reviews are AI-summarized from news channels, and other expert sources. Each summary is limited to 2 lines for quick reading.

Peer Comparison

Comparing with 2 listed peers
IPO P/E Ratio
57.91x
vs Peer Avg: 43.0x
IPO Market Cap
Rs 3497 Cr
Peer Avg: 8.7K Cr
IPO ROE
NA
CompanyMarket CapRevenuePATP/EROE
SM
Sahajanand Medical TechnologiesIPO
Rs 3497 CrRs 1218.73 CrRs 69.08 Cr57.91x10.35%
Poly Medicure Limited16K Cr1.9K Cr265 Cr51.2x9%
Laxmi Dental Limited1.1K Cr277.86 Cr26.43 Cr34.8x11.95%
Peer Average8.7K Cr1.1K Cr145.72 Cr43.0x10.5%

Quick Analysis

  • Sahajanand Medical Technologies's P/E of 57.91x is higher than the peer average of 43.0x, suggesting premium valuation.
  • ROE of 10.35% is below peer average (10.5%), indicating lower return on equity.
  • Market cap post-listing would place Sahajanand Medical Technologies below peer average in terms of size.

* All peer data is from publicly available sources. Financial figures are latest reported annual numbers.

Company Contact Details

Sahajanand Estate, Wakharia Wadi, Near Dabholi Char Rasta, Nani Ved, Ved Road, Surat, Gujarat - 395004
022 49564000
[email protected]
Visit Website

Green Flags

  • Established medical technology business with operations dating back to 2001.
  • Specialised portfolio of vascular and structural heart intervention devices.
  • Three manufacturing facilities across India and Thailand.
  • Research and development capabilities supported by two R&D centres.
  • 119 granted patents and 78 patent applications reported as of June 30, 2026.
  • FY26 total income of ₹1,218.73 Cr and PAT of ₹69.08 Cr, based on the supplied financial table.
  • Products marketed internationally, with a presence in multiple global markets.

Red Flags

  • The IPO is entirely an Offer for Sale, so the company receives no fresh capital from the issue.
  • IPO valuation is approximately 57.91x post-issue P/E based on the provided valuation data.
  • Return ratios were lower for the quarter ended June 30, 2026 than for FY26.
  • Total borrowings increased from ₹175.27 Cr in FY24 to ₹269.53 Cr in FY26.
  • Medical device development and manufacturing involve regulatory, clinical, product-quality and market-acceptance risks.
  • International operations expose the company to foreign-market regulations, competition and currency risks.
  • === END ===

IPO Lot Size

Investors can bid for a minimum of 43 shares and in multiples thereof.

ApplicationLotsSharesAmount
Retail (Min)143₹14,792
S-HNI (Min)14602₹2,07,088
B-HNI (Min)682,924₹10,05,856

Grey Market Premium

Sahajanand Medical Technologies IPO GMP Today

GMP trend chart and full day-by-day history

→

Subscription Status

Sahajanand Medical Technologies IPO Subscription

Live status, allotment chance and day-wise figures

→

Comparison Tool

Compare Sahajanand Medical Technologies with Other IPOs

Side-by-side comparison with GMP, subscription, and financial metrics

→

Frequently Asked Questions

What is the price band of Sahajanand Medical Technologies IPO?

The price band is Rs 327-344 per share. One lot contains 43 shares; its value at the upper price is Rs 14,792. Check the issue terms for the minimum application size applicable to your category.

What are the bidding dates for Sahajanand Medical Technologies IPO?

The scheduled bidding period is 15 Oct 2026 to 19 Oct 2026.

When is Sahajanand Medical Technologies IPO scheduled to list?

The scheduled listing date is 23 Oct 2026. The actual listing price is determined on the exchange, not by the grey market premium or an AI estimate.

Who is the registrar for Sahajanand Medical Technologies IPO?

MUFG Intime India Pvt. Ltd. is the registrar. See the allotment page for the available schedule and official checking link.

Who manages Sahajanand Medical Technologies IPO?

Lead manager information recorded for this issue: Motilal Oswal Investment Advisors Ltd.; Avendus Capital Pvt. Ltd.; HSBC Securities & Capital Markets (India) Pvt. Ltd.; Nuvama Wealth Management Ltd..

Disclaimer

IPOGyani is not SEBI registered and does not provide investment advice. All information is for educational purposes only.

AI predictions are probabilistic estimates based on historical data and market trends. Past performance is not indicative of future results.

GMP (Grey Market Premium) data is sourced from various unofficial channels and may not be accurate. Always verify from multiple sources.

Investors should do their own research (DYOR) and consult a SEBI registered advisor before investing.

Current IPO Pages

Explore detailed GMP, subscription and IPO analysis pages for the latest active issues.